Concepedia

Siyu Li

SL

Statistics

Publications

14

Citations

1K

H-Index

12

Active since

2016

Affiliations

Beijing University of Chinese Medicine(Current)

Regeneron (United States)

Chinese Academy of Medical Sciences & Peking Union Medical College

Memorial Sloan Kettering Cancer Center

China Academy of Chinese Medical Sciences

Siyu Li is an author at Beijing University of Chinese Medicine specializing in pharmacology, oncology, and medicine.

Publications per year

2016–2024

14

Publications

14

Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial

Dong‐Wan Kim, Ranee Mehra, Daniel S.W. Tan et al. · The Lancet Oncology · 2016 · 470 citations · Full text

Medicine, Oncology, Pharmacology +9

Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial

Thomas U. Marron, Maria Isabel Fiel, Pauline Hamon et al. · The Lancet. Gastroenterology & hepatology · 2022 · 218 citations · Full text

Medicine, Oncology, Chemotherapy +13

Cemiplimab Plus Chemotherapy Versus Chemotherapy Alone in Advanced NSCLC: 2-Year Follow-Up From the Phase 3 EMPOWER-Lung 3 Part 2 Trial

Tamta Makharadze, Miranda Gogishvili, Tamar Melkadze et al. · Journal of Thoracic Oncology · 2023 · 98 citations · Full text

Medicine, Oncology, Pharmacology +15

Protocol for conducting bibliometric analysis in biomedicine and related research using CiteSpace and VOSviewer software

Qiang Du, Rui Zhao, Qianyi Wan et al. · STAR Protocols · 2024 · 53 citations · Full text

Computing, Visualization, Data Visualization +15

Novel anti-obesity effect of scutellarein and potential underlying mechanism of actions

Yiguang Lin, Nina Ren, Siyu Li et al. · Biomedicine & Pharmacotherapy · 2019 · 44 citations · Full text

Life Sciences, Nutritional Sciences, Pharmacology +17

1–5 of 14